Cadence announces strategic plan to secure long-term nanufacture and supply of OFIRMEV(R)
Cadence announced a supply agreement with Laboratorios Grifols for development, manufacture and supply of commercial quantities of OFIRMEV (acetaminophen) injection in flexible plastic bags. The company has terminated its supply agreement for OFIRMEV in glass vials with Baxter Healthcare. March 05, 2013
